331 related articles for article (PubMed ID: 25663178)
1. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.
Srivastava K; Thakur D; Sharma S; Punekar YS
Pharmacoeconomics; 2015 May; 33(5):467-88. PubMed ID: 25663178
[TBL] [Abstract][Full Text] [Related]
2. Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review.
Dang-Tan T; Ismaila A; Zhang S; Zarotsky V; Bernauer M
BMC Res Notes; 2015 Sep; 8():464. PubMed ID: 26391471
[TBL] [Abstract][Full Text] [Related]
3. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review.
Iheanacho I; Zhang S; King D; Rizzo M; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2020; 15():439-460. PubMed ID: 32161455
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Literature Review of the Humanistic Burden of COPD.
Hurst JR; Siddiqui MK; Singh B; Varghese P; Holmgren U; de Nigris E
Int J Chron Obstruct Pulmon Dis; 2021; 16():1303-1314. PubMed ID: 34007170
[TBL] [Abstract][Full Text] [Related]
5. Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies.
Xie F; Kovic B; Jin X; He X; Wang M; Silvestre C
Pharmacoeconomics; 2016 Nov; 34(11):1087-1100. PubMed ID: 27339668
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation.
Nellesen D; Yee K; Chawla A; Lewis BE; Carson RT
J Manag Care Pharm; 2013; 19(9):755-64. PubMed ID: 24156644
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature.
Rehman AU; Hassali MAA; Muhammad SA; Harun SN; Shah S; Abbas S
Eur J Health Econ; 2020 Mar; 21(2):181-194. PubMed ID: 31564007
[TBL] [Abstract][Full Text] [Related]
8. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
[TBL] [Abstract][Full Text] [Related]
9. Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review.
Huang M; Haiderali A; Fox GE; Frederickson A; Cortes J; Fasching PA; O'Shaughnessy J
Pharmacoeconomics; 2022 May; 40(5):519-558. PubMed ID: 35112331
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study.
Punekar YS; Naya I; Small M; Holbrook T; Wood R; Mullerova H; Valle M
J Med Econ; 2017 Jan; 20(1):28-36. PubMed ID: 27564685
[TBL] [Abstract][Full Text] [Related]
11. Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review.
McDonald M; Patel DA; Keith MS; Snedecor SJ
Ocul Surf; 2016 Apr; 14(2):144-67. PubMed ID: 26733111
[TBL] [Abstract][Full Text] [Related]
12. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States.
Patel JG; Nagar SP; Dalal AA
Int J Chron Obstruct Pulmon Dis; 2014; 9():289-300. PubMed ID: 24672234
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of the Economic and Humanistic Burden of Gout.
Shields GE; Beard SM
Pharmacoeconomics; 2015 Oct; 33(10):1029-47. PubMed ID: 25969152
[TBL] [Abstract][Full Text] [Related]
14. Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature.
Alleman CJ; Westerhout KY; Hensen M; Chambers C; Stoker M; Long S; van Nooten FE
Diabetes Res Clin Pract; 2015 Aug; 109(2):215-25. PubMed ID: 26008721
[TBL] [Abstract][Full Text] [Related]
15. The burden of COPD in Spain: results from the Confronting COPD survey.
Izquierdo JL
Respir Med; 2003 Mar; 97 Suppl C():S61-9. PubMed ID: 12647944
[TBL] [Abstract][Full Text] [Related]
16. Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.
Foo J; Landis SH; Maskell J; Oh YM; van der Molen T; Han MK; Mannino DM; Ichinose M; Punekar Y
PLoS One; 2016; 11(4):e0152618. PubMed ID: 27092775
[TBL] [Abstract][Full Text] [Related]
17. The Economic Burden of Chronic Obstructive Pulmonary Disease in the Asia-Pacific Region: A Systematic Review.
Woo L; Smith HE; Sullivan SD
Value Health Reg Issues; 2019 May; 18():121-131. PubMed ID: 31051330
[TBL] [Abstract][Full Text] [Related]
18. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
19. The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature.
Anees Ur Rehman ; Ahmad Hassali MA; Muhammad SA; Shah S; Abbas S; Hyder Ali IAB; Salman A
Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):661-672. PubMed ID: 31596632
[No Abstract] [Full Text] [Related]
20. Economic analysis of the Confronting COPD survey: an overview of results.
Wouters EF
Respir Med; 2003 Mar; 97 Suppl C():S3-14. PubMed ID: 12647938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
